Do drug discount cards count toward your deductible?

Why a card purchase sits outside your plan

A pharmacy discount card is not insurance. When you hand one over, the pharmacy runs the purchase through the card's pricing instead of your plan, and you pay the card price in cash. Your plan never receives a claim, so it never records the amount toward your deductible, your out-of-pocket maximum or, for Medicare drug plans, the annual cap. That single fact is the whole answer to the title question, and it is why the right choice at the counter depends on more than which price is lower that day.

Medicare states the rule directly. On its page about weight loss drugs, Medicare.gov says discount cards are not considered creditable coverage, and that when you use them, instead of your Medicare plan, to buy drugs, it does not count toward your Medicare deductible or out-of-pocket maximum. It then advises comparing the card price with what you pay under your plan to make sure you get the best price. Its page on creditable coverage puts the category plainly: doctor samples, discount cards, free clinics and drug discount websites are not drug coverage.

Commercial plans are less uniform. A plan may allow you to submit a receipt for a cash purchase and credit it toward the deductible, or it may not. There is no federal rule that requires it to. The only reliable answer is the plan's own, in writing, before you rely on it.

What each kind of coverage does with a card purchase

Sources: Medicare.gov, Weight loss drugs and Creditable prescription drug coverage pages. Checked October 30, 2026.

The last row is easy to miss. A person who becomes eligible for Medicare and relies on discount cards instead of joining a drug plan is, in Medicare's terms, without creditable drug coverage. Medicare.gov says going 63 days or more without creditable coverage may mean a penalty when you later get Medicare drug coverage, generally paid as part of the monthly premium for as long as you have that coverage. A card can be the lower price today and the higher cost over a decade.

The law that lets the pharmacist tell you

Until 2018, some pharmacy contracts restricted pharmacists from telling insured customers when paying cash would cost less than their copay. Two federal laws signed on October 10, 2018 ended that for most coverage. The Patient Right to Know Drug Prices Act, Public Law 115-263, says a group health plan or a health insurer offering group or individual coverage shall not restrict, directly or indirectly, a pharmacy from informing an enrollee of any difference between the enrollee's out-of-pocket cost under the plan and the amount the person would pay without using any coverage, and must ensure its pharmacy benefit manager does not either. The Know the Lowest Price Act of 2018, Public Law 115-262, applies the same rule to Medicare Part D plans and Medicare Advantage drug plans, for plan years beginning on or after January 1, 2020.

The laws protect the pharmacy's freedom to tell you; they do not require the pharmacist to volunteer it at every fill. So the practical step is to ask: "What would this cost through my plan, and what would it cost without insurance?" If the cash or card price is lower, you then decide whether the deductible trade described below is worth it.

A worked decision: card price against plan price

This example is hypothetical. Every price and plan figure is invented to show the arithmetic. Suppose a monthly prescription costs $12 with a discount card and $30 through your plan while you are in the deductible. The plan has a $300 drug deductible, and once it is met, the same prescription costs a $5 copay.

The same two prices give opposite answers. In the first case, the deductible would take most of the year to meet, and every plan-route dollar before that is a dollar you would not have spent with the card. In the second case, the deductible is met early by other spending, so the plan price drops to the copay almost immediately and the card route costs more. The deciding question is not "which price is lower today" but "will I meet the deductible this year anyway, and when?"

The middle cases need a little more arithmetic. If other spending will meet the deductible in, say, June, the plan route costs the plan price until June and the copay after, and the card route costs the card price all year; you can also switch, using the card until the deductible is met and the plan after. Under Medicare drug plans, the card route also forgoes progress toward the annual out-of-pocket cap, which only matters in a year when your covered drug costs would reach it. The Part D out-of-pocket cap guide explains the cap and how to estimate whether you will reach it.

A counter checklist

1. Ask the pharmacist for both prices: through your plan, and without insurance or with a card.
2. If the card is lower, ask yourself whether other spending will meet your deductible this year, and roughly when.
3. If you have Medicare drug coverage, remember the card route adds nothing toward the deductible or the annual cap.
4. If you have a commercial plan, ask the plan in writing whether it credits cash purchases toward the deductible and how to submit them.
5. Keep the receipt for every card fill with the date, drug, strength, quantity and amount.
6. Recheck at each refill: plan prices change after the deductible is met, and card prices can change too.

For the wider choice between paying cash and using insurance for medical services, not drugs, paying cash and your deductible works the same trade for procedures, and the HDHP cost math guide shows how drug costs enter a full-year plan comparison. Glucose monitor sensors are a common case where the pharmacy counter is not a drug-plan purchase at all: Medicare covers them under Part B, and the Medicare CGM cost guide shows the monthly amount and how assignment decides what you pay.

What pharmacies pay: brand against generic in the NADAC file

Prices at the counter start from what the pharmacy paid for the drug. CMS publishes that cost every week as the National Average Drug Acquisition Cost, or NADAC. Medicaid.gov describes it as built by averaging survey invoice prices from retail community pharmacies, independent and chain, across the United States, focused on their acquisition costs. It is what the pharmacy paid per unit, not a retail price and not what you pay: it leaves out the pharmacy's dispensing fee and any markup, and a plan's negotiated price or a card's price is set separately.

The table below copies the NADAC per-tablet figures for five brand and generic pairs from the CMS NADAC 2026 file, rows with effective date 2026-10-21 and as-of date 2026-10-28, and multiplies each by 30 tablets, a stated input for one tablet a day for a month.

Source: CMS, National Average Drug Acquisition Cost (NADAC) 2026, data.medicaid.gov, effective 2026-10-21, as of 2026-10-28, retrieved 2026-10-30. NADAC is pharmacy acquisition cost, not a retail price and not what you pay; it excludes dispensing fees. The 30-tablet columns are our multiplication. Listing a drug here is not a statement about its use.

Read the table as cost structure, not as prices. For Lipitor 20 mg, pharmacies paid an average of $19.05841 per tablet, $571.75 for 30, while generic atorvastatin 20 mg cost them $0.02858 per tablet, $0.86 for 30. When the pharmacy's own cost for a month of a generic is under a dollar, almost all of what you pay at the counter for that generic is dispensing fee, margin and the pricing rules of whichever route you use, the plan or a card. That is why card prices for common generics can undercut plan copays, and why the same card rarely does as much for a brand whose acquisition cost alone is hundreds of dollars a month.

The file also contains brand products with no generic row. For example, ELIQUIS 5 MG TABLET appears at $5.52144 per tablet in the same weekly file with no corresponding generic figure. For drugs like that, the generic-against-brand comparison does not exist yet, and the plan's coverage, a manufacturer program, or Medicare's own rules usually matter more than a discount card.

The middle case, worked: switching routes mid-year

Continuing the hypothetical above, with the same invented prices. Suppose other prescriptions will meet the $300 deductible at the start of month 6. Staying on the plan route all year costs 5 fills at $30 and then 7 at the $5 copay: $185.00. Using the card for the first 5 months and the plan after costs 5 x $12 plus 7 x $5: $95.00. Using the card all year costs $144.00. In this case the switch is the lowest-cost route, because the card fills in the early months would not have been the ones that met the deductible anyway. The calculation only works if you know roughly when other spending will meet the deductible, which is why a household's other prescriptions belong in the decision.

Why 30-day and 90-day fills compare differently

Supply length changes the comparison in a way the NADAC figures make visible. For a common generic, the drug itself is a small part of any price, so whatever a pharmacy or a card charges per fill, rather than per tablet, is most of the bill. The table multiplies the generic NADAC figures above by 30 and by 90 tablets, stated inputs for one tablet a day, and shows the brand at 90 tablets for scale.

Source: CMS NADAC 2026, effective 2026-10-21, as of 2026-10-28. Acquisition cost only, multiplied by MyCarePrice; not a price you will pay.

Even at 90 tablets, the acquisition cost of each generic in the table stays in single dollars. So when a 90-day fill of a common generic costs much less than three 30-day fills at the counter, the saving comes from fewer per-fill charges, not from the drug. For brands the opposite holds: the drug dominates the price at any supply length, and a card's percentage off a brand price, if it offers one, applies to a large number. Ask for both supply lengths when you compare, through the plan and with a card, and check whether your plan's copay is per fill or scaled to the supply.

A year-long price log

Because the right route changes during the year, a simple log does more than any single comparison. Keep one row per fill.

The last column is the one to watch. Medicare drug plans send monthly statements with the running totals, and commercial plans show them on the explanation of benefits or the member portal. When the plan's running total is close to the deductible, the plan route usually becomes the better one for every fill after it. The log also gives you the receipts you need if your commercial plan later agrees to credit card purchases.

Why generics cost less, in the FDA's words

The FDA's generic drug facts page explains the structure. A generic medicine has the same active ingredient as the brand-name drug and is bioequivalent to it. Generic makers do not have to repeat the animal and clinical studies that were required of the brand-name medicine to show safety and effectiveness, which lowers their costs. New brand-name drugs are usually protected by patents that prohibit others from selling generics of the same drug, and a generic can receive final FDA approval once those patents and marketing exclusivities expire.

On price, the FDA ties the savings to competition: the more generic makers sell the same drug, the larger the price reductions it reports, and it cites an estimate that generic drugs saved the U.S. health care system $2.2 trillion from 2009 to 2019. Those statements are from its page last updated November 1, 2021. They describe markets, not your pharmacy bill. Whether a generic is dispensed in place of a brand depends on the prescription and your state's pharmacy substitution rules, which the pharmacist applies; questions about whether a particular switch is appropriate belong with the prescriber or pharmacist.

Generic rules, prior authorization, Extra Help and paid plans

• A plan that requires generics. A plan can charge more, or pay less, when a brand is dispensed where a generic is available. If you fill a brand with a card to avoid that, the purchase still sits outside the plan.
• Prior authorization or step therapy. A drug that needs plan approval can look cheaper with a card while the approval is pending. Paying cash in the meantime does not count toward the deductible unless the plan credits it. The prior authorization guide explains how approvals work and what a reference number proves.
• Extra Help. People with Medicare who qualify for Extra Help have their own, lower cost sharing set by CMS, which can make the plan route cheaper than any card.
• The Medicare monthly payment option. Under the Medicare Prescription Payment Plan, plan-route costs can be spread across the year; card purchases are outside it.
• Switching mid-year. Nothing stops you using a card for one fill and the plan for the next. Keep receipts for card fills in case your plan later agrees to credit them.
• Paid discount plans. A free pharmacy discount card and a paid medical discount plan are different products. The FTC's June 18, 2025 consumer alert says pressure to act fast is a sign of a scam and advises getting details in writing before you sign up.

What to ask your plan, word for word

Because the commercial-plan answer is plan-specific, the call or secure message to the plan is the step that settles it. Ask these four questions and keep the reply:

• "If I buy a covered prescription with a discount card or for cash at an in-network pharmacy, will you credit the amount toward my deductible and out-of-pocket maximum if I submit the receipt?"
• "If yes, what form do you need, what must the receipt show, and is there a deadline after the fill date?"
• "Do you credit the amount I paid, or your own negotiated price for the drug, whichever is lower?"
• "Does the answer change for a drug that needs prior authorization or is not on your formulary?"

A written yes with a form and a deadline turns the card route into a no-lose option for that plan: you pay the lower card price and still make progress toward the deductible. A written no means the worked decision above applies as stated. Either way, you are deciding from the plan's rule rather than from an assumption.

Discount cards and deductibles: reader questions

Laws, agency pages and price files cited

• Medicare.gov, Weight loss drugs: discount cards are not creditable coverage and do not count toward the Medicare deductible or out-of-pocket maximum. Checked October 30, 2026.
• Medicare.gov, Creditable prescription drug coverage: discount cards are not drug coverage; the 63-day rule and late enrollment penalty. Checked October 30, 2026.
• Public Law 115-263, Patient Right to Know Drug Prices Act, October 10, 2018. Checked October 30, 2026.
• Public Law 115-262, Know the Lowest Price Act of 2018, October 10, 2018, effective for plan years from January 1, 2020. Checked October 30, 2026.
• CMS, National Average Drug Acquisition Cost (NADAC) 2026, data.medicaid.gov, rows effective 2026-10-21, as of 2026-10-28; and Medicaid.gov, Retail Price Survey, description of the NADAC. Checked October 30, 2026.
• U.S. Food and Drug Administration, Generic Drug Facts (page updated November 1, 2021). Checked October 30, 2026.
• Federal Trade Commission, Is it health insurance or a medical discount plan?, consumer alert, June 18, 2025. Checked October 30, 2026.

General price and payment information, not medical, legal or insurance advice. NADAC figures are pharmacy acquisition costs, not prices you will pay. Confirm your price before you fill.